Vimarsana
Biggest News Aggregation in the World

Janssen Collaboration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janssen Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janssen Collaboration Today - Breaking & Trending Today

Cidara Therapeutics : Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Form 8-K -November 02, 2023 at 04:25 pm EDT - Vimarsana News

Cidara Therapeutics : Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Form 8-K -November 02, 2023 at 04:25 pm EDT

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results SAN DIEGO, November 2, 2023- Cidara Therapeutics, Inc. , a biotechnology company...

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Vimarsana News

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted th...

Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program - Vimarsana News

Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program

SAN DIEGO, July 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious...

Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, ... - Vimarsana News

Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, ...

Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, ...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - Vimarsana News

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. ("Fate" or...